Description
There is no detailed description, see related
Used in the treatment of
- Y47.1 Adverse effects in therapeutic use, benzodiazepines
- Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
- Z71.5 Drug abuse counselling and surveillance
- Z100* CHAPTER XXII Surgical practice
- L73.8.1* Folliculitis
- D74.9 Methaemoglobinaemia, unspecified
- A41.9 Sepsis, unspecified
- F11 Mental and behavioural disorders due to use of opioids
- I20 Angina pectoris
- I95.9 Hypotension, unspecified
- L08.0 Pyoderma
- M13.9 Arthritis, unspecified
- M79.2 Neuralgia and neuritis, unspecified
- N30 Cystitis
- N34 Urethritis and urethral syndrome
- N39.0 Urinary tract infection, site not specified
- R58 Haemorrhage, not elsewhere classified
- R68.8 Other specified general symptoms and signs
- B86 Scabies
- T30 Burn and corrosion, body region unspecified
- T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
- T40.2 Poisoning, other opioids
- T42.4 Poisoning, benzodiazepines
- T51 Toxic effect of alcohol
- T56 Toxic effect of metals
- T56.0 Toxic effect, lead and its compounds
- T56.1 Toxic effect, mercury and its compounds
- T57.0 Toxic effect, arsenic and its compounds
- T57.8 Toxic effect, other specified inorganic substances
- T58 Toxic effect of carbon monoxide
- T59.6 Toxic effect, hydrogen sulfide
- T65.0 Toxic effect, cyanides
- T65.5 Toxic effect, nitroglycerin and other nitric acids and esters
- T65.6 Toxic effect, paints and dyes, not elsewhere classified
- T78.4 Allergy, unspecified